Specialty Pharmacy

The more orders pharmacists have to verify, the more likely they are to make mistakes.

MS advocacy group provides a wide range of services that help patients manage the disease.

Average reimbursement for Part B oncology drugs is 52% higher in 340B hospitals than in community cancer clinics.

Drug that targets interaction with RNA does not damage other proteins.

Treatment seeks to reverse chemotherapy resistance caused by P-glycoprotein.

mHealth apps greatly improve the accuracy and convenience of data collection.

Treatment shows rapid and significant improvements in signs and symptoms of RA after 24 weeks of treatment.

Chronic lymphocytic leukemia treatment reprograms T cells to hunt and kill cancer cells.

Greater pharmacist involvement in care transitions could curb the many medication discrepancies that arise throughout the process.

Study reveals targets on the tumor cell that can be recognized by killer T-cells.

Top recent developments in cancer research.

Planned Parenthood funding cuts would save taxpayers $235 million over a decade, but also reduce health care access for nearly 400,000 women and children.

Physical and mental impairments prevent MS patients from being engaged in social and community activities.

Clinical signs and symptoms of RA may be preceded by a preclinical phase lasting several years.

GOLD group classification system could not predict lung function decline.

Top stories in Specialty Pharmacy Times.

Lymphoma and lung cancer present significant risk to RA patients.

Active ingredient in marijuana THC may improve acceptance of transplanted organs.

Birth control use not found to impact disease progression.

Patients who received immediate treatment recommendations saw improved symptom control.

Research will lead to novel viral and immunologic treatments.

Research may lead to antibody treatment to inhibit HIV.

Implications of the IPF treatment for caregivers and patients.

Study finds most patients with Lynch syndrome are unaware they have the syndrome.

Combination of immunotherapy and aspirin showed a substantial decrease in bowel and melanoma skin cancer growth in mice.

Genetic variants regulate immune cells with important roles in immunodeficiency disorders.

Inflammation and joint damage might not be the only factor causing pain in rheumatoid arthritis.

Treatment removes a tumor's defenses.